Recipharm’s fifteen facilities are now fully prepared for drug serialization and have delivered serialized batches within Europe ahead of the February 9th deadline. During the period 2016-2018, the company invested €35 million into its operations and launched a three-year program to provide a compliant serialization, ahead of the introduction of the EU Falsified Medicines Directive (EU FMD) and the US Drug Supply Chain Security Act (DSCSA). All of the facilities are connected to customers to al...